Navigation Links
Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients
Date:10/15/2010

for the treatment of multiple sclerosis with a comprehensive clinical development program which has been launched in monotherapy. First Phase II study results of the safety and efficacy of teriflunomide monotherapy in MS were published in Neurology in 2006. In addition to the TEMSO trial, two other Phase III trials, TOWER and TENERE, are ongoing in RMS patients. A Phase III study, TOPIC, is also underway in early MS or CIS (Clinically isolated syndrome). Teriflunomide has also been evaluated as an adjunct therapy to either interferon beta or glatiramer acetate in two Phase II studies. Results of these studies were presented earlier this year during the American Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) and American Academy of Neurology (AAN) meetings respectively. Phase II studies with teriflunomide (7 and 14mg) in adjunct with IFNbeta demonstrated an improvement in MRI outcomes, with a consistent safety profile in patients treated with the adjunct therapy compared to patients treated with IFNbeta and receiving placebo. In the other Phase II study, teriflunomide in adjunct to glatiramer acetate (GA) was well-tolerated compared to patients receiving GA and placebo and showed a numerical trend for the reduction in number and volume of gadolinium enhancing T-1 brain MRI lesions in the adjunct arm compared to the placebo with GA arm.

About the TEMSO Study

TEMSO is a 2-year randomized, double-blind, placebo-controlled multinational study including 1,088 RMS patients aged 18-55 years from 21 countries, with an Expanded Disability Status Scale (EDSS) is less than or equal to 5.5 and at least one relapse in the previous year or at least 2 relapses in the preceding 2 years. Patients were randomized to placebo or teriflunomide, 7 or 14mg, once daily and followed for 108 weeks. The primary endpoint was annualized relapse rate defined as the number of confirmed relapses per patient-year. The key secondary endpoint was the time to sust
'/>"/>

SOURCE Sanofi-aventis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Medisafe 1 Technologies Successfully Tests Prototype of Patented Syringe Locking Device
2. Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Penwest Pharmaceuticals
3. Transcatheter Technologies Successfully Performs in Vivo Implantation of the Trinity Transapical Aortic Valve System
4. Omeros Successfully Unlocks Orphan GPCRs
5. NeuroDerm Successfully Completes Enrollment and Dosing in a Phase 1 Clinical Study of ND0611 Dermal Patch for Parkinsons Disease
6. QRxPharma Successfully Completes Comparative Phase 1 Proof-of-Concept Study for MoxDuo(R) CR Tablet Formulation
7. MedAvante Opens Moscow Office and Successfully Completes First Centralized Ratings Assessment
8. Simcere Pharmaceutical Group Successfully Completes Endostar Phase IV Clinical Study
9. Sanofi-aventis Successfully Completes The Acquisition of Chattem, Inc.
10. Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc.
11. Phonak Successfully Hosts Hearing Care for Adults 2009 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015  Dedicated to promoting ... Leonard,s® Healthcare Corp. took the purple pledge in ... is Alzheimer,s & Brain-Awareness Month, a time to shine ... the world and all the people in our community ... those struggling with the disease, and helps mobilize friends, ...
(Date:7/7/2015)... BANGALORE , July 7, 2015 /PRNewswire/ ... provider of innovative clinical trial data management solutions, has ... Reports) recent publication named " EDC and eCOA / ... ISR Reports is one of the leading providers of ... report evaluated 22 EDC and eCOA / ePRO tools ...
(Date:7/7/2015)... July 7, 2015   Bionik Laboratories Corp. ... company with a core focus in robotic exoskeleton ... the "Company"), announced today that it has completed ... units consisting of its common stock and warrants ... in a private placement transaction.  This equity financing ...
Breaking Medicine Technology:Purple for a Purpose: Supporting Alzheimer's & Brain-Awareness Month 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 3Bionik Laboratories Completes US$13.1 Million Private Placement 2Bionik Laboratories Completes US$13.1 Million Private Placement 3
... , , , ROCKVILLE, Md., ... of getting breast cancer, but each drug carries distinct potential harms ... for Healthcare Research and Quality. , , Drugs ... women with a family history of breast cancer or other risk ...
... , HONG KONG, Sept. 15 ... pro-healing stent, OrbusNeich,s Genous Bio-engineered R stent, and preclinical data ... week at the Transcatheter Cardiovascular Therapeutics symposium, TCT 2009, in ... M.D., Ph.D., of the Academic Medical Center in Amsterdam will ...
Cached Medicine Technology:Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects, New Report Says 2Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects, New Report Says 3Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2009 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2009 3
(Date:7/7/2015)... (PRWEB) , ... July 07, ... ... Refining convenience stores throughout the Southwest, including Giant, Mustang, Sun Dial and ... mobile program, surpassing their original 2015 fundraising goal by nearly $100,000, to ...
(Date:7/7/2015)... ... July 07, 2015 , ... A ... facial rejuvenation that have emerged about Hillary Clinton. Two plastic surgeons consulted by ... more youthful than she has in some time and speculate that she might ...
(Date:7/7/2015)... ... ... Quadrino Law Group is pleased to announce the relocation of the firm's headquarters to ... is a state of the art building, located with easy access to New York ... said, "We are pleased to service our clients from such a premier location and ...
(Date:7/7/2015)... , ... July 07, 2015 , ... Safe Catch is ... single fish for mercury. Albertsons, Gelson’s Markets, New Leaf Community Markets, Sprouts Farmers Market ... , “We developed the technology to test every fish for mercury,” said Safe Catch ...
(Date:7/7/2015)... ... July 07, 2015 , ... Parents and guardians of teenagers or young ... an open-ended holistic treatment center for drug and alcohol abuse located in Southwest Michigan. ... Research has shown a significant increase in the “club drug” use among high school ...
Breaking Medicine News(10 mins):Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2
... entities in the addiction treatment field announced the launch ... (ACTION) Campaign for the improvement of addiction treatment services. ... addiction treatment for individuals in need and to keep ... during National Recovery Month in September, has a goal ...
... APFC ), today announced that Chairman and Chief,Executive ... Operating,officer, Dr. Joseph Carleone, and Vice President and Chief ... the CIBC World Market,2nd Annual Industrials Conference, October 2-3, ... is available on the Company,s web site. About ...
... A combined treatment with rapamycin and Gleevec might reverse ... liver disease, according to the results of a new ... issue of Hepatology, a journal published by John Wiley ... the Study of Liver Diseases (AASLD). The article is ...
... either therapy alone, researchers found , MONDAY, Oct. ... therapy plus antidepressant drugs is the best way to ... depressed teens, new research shows. , The Duke University-led ... journal Archives of General Psychiatry . , The ...
... America,s Leading Heart Hospital and National Foundation Established By, Talk- Show Host ... ... Least Afford It, CLEVELAND, Oct. 1 Cleveland Clinic and ... save lives. The renewed agreement places Cleveland Clinic among a select ...
... Mutter ... "Up the alley and down the street Fallon and Broom sell bones and meat., Fallon,s ... ... Need fresh cadavers? Fallon and,Broom are two, uh, gentlemen who would be happy to fulfill your request. ...
Cached Medicine News:Health News:Leaders in addiction treatment announce national 'ACTION' campaign 2Health News:Combination therapy reverses effects of portal hypertension in rats 2Health News:Drug Plus Psychotherapy Best Treatment for Depressed Teens 2Health News:Cleveland Clinic and The Larry King Cardiac Foundation Partner to Provide Heart Surgery to Those in Need 2Health News:Cleveland Clinic and The Larry King Cardiac Foundation Partner to Provide Heart Surgery to Those in Need 3Health News:Wanted: Dead Bodies (Fresh, Preferably) 2
... Re-insulation capabilities that extend the life of ... bring them back to life, expertise you ... trademark. Our maintenance capabilities always help you ... Economical and fast, not only do we ...
... know their instruments will consistently perform correctly. ... Instrument for instrument repair than any other ... carbide inserts and all repairs are micro-inspected ... enjoy 24-hour turnaround from our repair center ...
... fiber and video scopes including bronchoscopes, cystoscopes, ... OR and endoscopy. Quality is of utmost ... the standards of the OEM. We back ... defects in materials and workmanship. Quotes are ...
Inquire...
Medicine Products: